Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT04607980

Public ClinicalTrials.gov record NCT04607980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Efficacy and Safety of ABP 654 Compared With Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis

Study identification

NCT ID
NCT04607980
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
563 participants

Conditions and interventions

Interventions

  • ABP 654 Drug
  • Ustekinumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 10, 2020
Primary completion
Jan 12, 2022
Completion
Jun 2, 2022
Last update posted
Dec 11, 2024

2020 – 2022

United States locations

U.S. sites
34
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center PC Birmingham Alabama 35205
Alliance Dermatology and Mohs Center Phoenix Arizona 85032
First OC Dermatology Fountain Valley California 92708
University Clinical Trials, Inc. San Diego California 92123
San Luis Dermatology and Laser Clinic - Dermatology San Luis Obispo California 93405
Clinical Science Institute Santa Monica California 90404
Unison Clinical Trials Sherman Oaks California 91403
Revival Research Doral Florida 33122
International Dermatology Research, Inc Miami Florida 33144
Renstar Medical Research Ocala Florida 34470
Moore Clinical Research Inc. Tampa Florida 33609-2230
NorthShore University HealthSystem Skokie Illinois 60077
Springfield Clinic Springfield Illinois 62703-2403
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250-2041
Epiphany Dermatology of Kansas, LLC Overland Park Kansas 66210
DelRicht Research Baton Rouge Louisiana 70809
ALLCUTIS Research, LLC. Beverly Massachusetts 01915
Metro Boston Clinical Partners Brighton Massachusetts 02135
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520
Dermatology Consulting Services, PLLC High Point North Carolina 27262
Wilmington Dermatology Center Wilmington North Carolina 28405
Bexley Dermatology Research Bexley Ohio 43209-2421
Dermatologists of Southwest Ohio Mason Ohio 45040
Oregon Dermatology and Research Center Portland Oregon 97210
Oregon Medical Research Center Portland Oregon 97223
The Pennsylvania Centre for Dermatology, LLC Exton Pennsylvania 19341
Clinical Partners, LLC Johnston Rhode Island 02919
The Skin Wellness Center PC Knoxville Tennessee 37922
Center for Clinical Studies Cypress Texas 77433
Modern Research Associates Dallas Texas 75231
Austin Institute for Clinical Research - Dermatology Houston Texas 77056
Progressive Clinical Research [Texas] San Antonio Texas 78213
Acclaim Dermatology Sugar Land Texas 77479-2645

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04607980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 11, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04607980 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →